Preoperative statin treatment is associated with reduced postoperative mortality after isolated cardiac valve surgery in high-risk patients

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 24, Issue 6, 2010, Pages 921-926

  Allou, Nicolas ^a   Augustin, Pascal ^a   Dufour, Guillaume ^a   Tini, Laura ^a   Ibrahim, Hassan ^a   Dilly, Marie Pierre ^a   Montravers, Philippe ^a   Wallace, Joshua ^a   Provenchre, Sophie ^a   Philip, Ivan ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Cardiac valve surgery; Cardiovascular risk; Postoperative mortality; Statin

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VALVE SURGERY; HIGH RISK POPULATION; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RISK FACTOR; SURGICAL MORTALITY;

ADULT; AGED; ANESTHESIA; BODY MASS INDEX; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; ENDPOINT DETERMINATION; FEMALE; HEART VALVES; HEMODYNAMICS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROPENSITY SCORE; RISK; RISK FACTORS;

EID: 78649511387     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2010.03.017     Document Type: Article

References (30)

1. J.K. Plenge, T.L. Hernandez, and K.M. Weil Simvastatin lowers C-reactive protein within 14 days: An effect independent of low-density lipoprotein cholesterol reduction Circulation 106 2002 1447 1452
2. J.A. Beckman, J.K. Liao, and S. Hurley Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein Circ Res 95 2004 217 223
3. J.R. Downs, M. Clearfield, and S. Weis Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS Air Force/Texas Coronary Atherosclerosis Prevention Study JAMA 279 1998 1615 1622
4. P.K. Lindenauer, P. Pekow, and K. Wang Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery JAMA 291 2004 2092 2099
5. D. Poldermans, J.J. Bax, and M.D. Kertai Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery Circulation 107 2003 1848 1851
6. W. Pan, T. Pintar, and J. Anton Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery Circulation 110 2004 II45 II49
7. O.J. Liakopoulos, Y.H. Choi, and P.L. Haldenwang Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: A meta-analysis of over 30,000 patients Eur Heart J 29 2008 1548 1559
8. A. Ouattara, H. Benhaoua, and Y. Le Manach Preoperative statin therapy is associated with a significant and dose-dependent reduction of adverse cardiovascular outcomes after coronary artery bypass graft surgery J Cardiothorac Vasc Anesth 23 2009 633 638
9. L.L. Clark, J.S. Ikonomidis, and F.A. Crawford Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: An 8-year retrospective cohort study J Thorac Cardiovasc Surg 131 2006 679 685
10. L.M. Fedoruk, H. Wang, and M.R. Conaway Statin therapy improves outcomes after valvular heart surgery Ann Thorac Surg 85 2008 1521 1526
11. M. Tabata, Z. Khalpey, and L. Cohn Effect of preoperative statins in patients without coronary artery disease who undergo cardiac surgery J Thorac Cardiovasc Surg 136 2008 1510 1513
12. S.S. Virani, V. Nambi, and V.V. Lee Does preoperative statin therapy improve outcomes in patients undergoing isolated cardiac valve surgery ? Am J Cardiol 102 2008 1235 1239
13. D.T. Mangano, E.L. Layug, and A. Wallace Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery Multicenter Study of Perioperative Ischemia Research Group N Engl J Med 335 1996 1713 1720
14. P.K. Lindenauer, P. Pekow, and K. Wang Perioperative beta-blocker therapy and mortality after major noncardiac surgery N Engl J Med 353 2005 349 361 (Pubitemid 41132339)
15. E. Ohman, D. Bhatt, and P. Steg The REduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design Am Heart J 151 2006 786.e1 786.e10
16. R.B. D'Agostino Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281
17. J. Lunceford, and M. Davidian Stratification and weighting via the propensity score in estimation of causal treatment effects: A comparative study Stat Med 23 2004 2937 2960
18. Y. Le Manach, G. Godet, and P. Coriat The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery Anesth Analg 104 2007 1326 1333
19. O. Schouten, S.E. Hoeks, and G.M. Welten Effect of statin withdrawal on frequency of cardiac events after vascular surgery Am J Cardiol 100 2007 316 320
20. C. Heeschen, C.W. Hamm, and U. Laufs Withdrawal of statins increases event rates in patients with acute coronary syndromes Circulation 105 2002 1446 1452
21. T. Lee, E. Marcantonio, and C. Mangione Derivation and prospective validation of a simplex index for prediction of cardiovascular risk for major noncardiac surgery Circulation 100 1999 1043 1049
22. S. Nashef, F. Roques, and P. Michel European system for cardiac operative risk evaluation (EuroSCORE) Eur J Cardiothorac Surg 16 1999 9 13
23. M. Cooney, A. Dudina, and I. Graham Value and limitations of existing scores for the assessment of cardiovascular risk J Am Coll Cardiol 54 2009 1209-1027
24. E. Boersma, D. Poldermans, and J.J. Bax Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy JAMA 285 2001 1865 1873
25. A.M. Lefer, B. Campbell, and Y.K. Shin Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts Circulation 100 1999 178 184
26. S. Bellosta, N. Ferri, and L. Arnaboldi Pleiotropic effects of statins in atherosclerosis and diabetes Diabetes Care 23 suppl 2 2000 B72 B78
27. K.K. Koh Effects of statins on vascular wall: Vasomotor function, inflammation, and plaque stability Cardiovasc Res 47 2000 648 657
28. M. Crisby, G. Nordin-Fredriksson, and P.K. Shah Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization Circulation 103 2001 926 933
29. J. Ambrose, and V. Fuster The risk of coronary occlusion is not proportional to the prior severity of coronary stenoses Heart 79 1998 3 4
30. M. Chello, G. Patti, and D. Candura Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery Crit Care Med 34 2006 660 667